TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
RVMD

Revolution Medicines Inc

Healthcare · Biotechnology

205.00$ +2.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Revolution Medicines Inc (RVMD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 4,323 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RVMD
Line item Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
171 – – 235 221 454 454 595 567 812 774 735 738 683 633 826 812 1,073 1,074 984 2,062 1,908 1,808 1,763 2,558 2,365 2,430 2,252 2,355 2,254 4,323
85 70 – 149 134 362 340 483 454 697 661 624 590 534 483 675 660 923 922 824 1,879 1,729 1,625 1,579 2,328 2,135 2,176 1,977 2,075 1,968 4,028
70 -70 – 22 17 183 24 65 104 352 196 129 108 98 106 179 161 427 380 358 696 288 276 201 543 334 402 217 384 441 815
70 70 – 136 123 348 325 466 441 682 646 609 577 519 461 655 645 910 909 813 1,853 1,704 1,591 1,549 2,289 2,103 2,137 1,932 2,026 1,908 3,938
7.3 – – 9.0 8.7 8.5 7.3 9.3 6.4 7.6 6.5 7.4 5.9 5.4 5.6 4.9 4.7 4.0 2.5 0.3 1.3 0.0 0.0 0.0 0.0 – – – – – –
6.6 – – 0.0 0.0 – 0.0 – – 0.0 0.0 0.0 -13 – – 0.0 0.0 – 0.0 0.0 0.0 – – – – – – – – – –
6.9 – – 6.8 7.1 15 36 35 8.9 11 37 35 71 13 16 18 74 19 73 – – – – – – – – – – – –
15 – – 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15 15
63 – – 62 62 62 61 61 61 61 60 60 60 60 59 59 59 59 58 58 58 57 57 57 57 56 56 56 56 56 56
74 – – 69 68 69 93 90 93 89 89 97 135 132 134 144 127 121 143 147 236 183 190 197 293 287 564 655 723 754 1,717
31 – – 39 43 42 44 42 47 44 46 52 60 57 64 73 62 55 78 86 144 94 105 111 164 159 185 246 290 290 354
0.1 – – 0.2 0.2 3.4 3.7 3.7 3.7 3.7 4.9 5.0 6.2 6.3 6.0 7.0 6.8 5.9 5.7 5.8 7.4 8.2 8.3 8.4 13 13 13 16 16 17 17
5.2 – – 6.0 11 7.9 10 6.7 13 9.7 10 10 14 14 14 24 21 20 30 30 62 32 29 24 54 48 57 75 65 81 88
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – 487
97 97 – 166 153 385 360 505 475 723 685 638 603 551 499 681 685 952 931 837 1,826 1,725 1,619 1,566 2,265 2,078 1,865 1,597 1,631 1,500 2,606
-110 – – -143 -157 -177 -204 -231 -266 -303 -347 -400 -453 -510 -572 -645 -701 -769 -868 -976 -1,138 -1,254 -1,387 -1,543 -1,738 -1,951 -2,199 -2,504 -2,869 -3,323 -3,967
36 36 36 36 36 29 59 65 66 70 73 74 74 74 74 85 89 95 107 109 141 165 165 167 168 188 188 189 190 198 211

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?